Siltuximab
ATC L04AC11 · 10 markets · 21 records
AU 5 records · 3 strengths
- 100 mginjectionSylvantSYLVANT siltuximab (rmc) 100mg powder for injection vial
- 400 mginjectionSylvantSYLVANT siltuximab (rmc) 100mg powder for injection vial
Records without a stated strength · 1 Sylvant
US 2 records · 2 strengths
GB 2 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
- 400 mg/vialinjectionSYLVANT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
- 100 mg/vialinjectionSYLVANT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
CN 2 records · 2 strengths
TW 2 records · 2 strengths
- 100 mginjectionSylvant® Powder for Concentrate for Solution for Infusion 400mg薩溫珂®凍晶注射劑100毫克
- 400 mginjectionSylvant® Powder for Concentrate for Solution for Infusion 400mg薩溫珂®凍晶注射劑400毫克
HK 2 records · 1 strengths
Records without a stated strength · 1 Sylvant® Powder for Concentrate for Solution for Infusion 400mg
ES 1 records · 1 strengths
- 100 mginjectionSylvant
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Sylvant
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg injection | Sylvant | Sylvant 400mg powder for concentrate for solution for infusion vials | Sylvant SYLVANT siltuximab (rmc) 100mg powder for injection vial | 萨温珂司妥昔单抗 | Sylvant | Sylvant® Powder for Concentrate for Solution for Infusion 400mg 薩溫珂®凍晶注射劑100毫克 | ||||
| 400 mg injection | Sylvant | Sylvant 400mg powder for concentrate for solution for infusion vials | Sylvant SYLVANT siltuximab (rmc) 100mg powder for injection vial | 萨温珂司妥昔单抗 | Sylvant® Powder for Concentrate for Solution for Infusion 400mg 薩溫珂®凍晶注射劑400毫克 | |||||
| 400 mg/vial injection | SYLVANT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL | |||||||||
| 100 mg/vial injection | SYLVANT POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL | |||||||||
| 400 mg powder | Sylvant | |||||||||
| 100 mg powder | Sylvant | |||||||||
unknown | Sylvant | Sylvant® Powder for Concentrate for Solution for Infusion 400mg | Sylvant |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · SG 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 CA · SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.